Aerobika Oscillating Positive Expiratory Pressure (OPEP) Device
Reduces COPD readmissions by 28% in the critical 30-day period
Trend toward shorter length of stay
Reduced use of oral corticosteroids and antibiotic treatments
Improves lung function and ventilation in COPD
Reduces post-operative readmissions by 39% in the critical 30-day period
Use of the device resulted in shorter length of stay and significantly lower costs
Cost effective addition to standard of care
Drug free, natural airway clearance
Clinically proven to assist mucus clearancei
Decreases cough frequencyi
Reduces COPD exacerbations by 28% in the critical 30 day periodii
Can help prevent 1 hospitalization for every 17 patients treated within 30 daysii
Improves lung function and ventilation in COPDi
Cost effective addition to standard of careiii
Purpose designed aerosol pathway for effective combined treatments
Copyright © 2025 HEALTHWAY. All Rights Reserved.